Bentham Science Logo

Track Your Manuscript:


Current Cancer Drug Targets

Volume 21, 11 Issues, 2021
ISSN: 1873-5576 (Online)
ISSN: 1568-0096 (Print)
This journal supports open access

In the current pandemic scenario, publication process of all articles related to Coronavirus will be expedited, for timely publication of much needed research

Contents

Current Cancer Drug Targets, Volume 18 - Number 1




Review Article

Is there a Role for Epigenetic Enhancement of Immunomodulatory Approaches to Cancer Treatment?

, 18(1): 5 - 15

Kirsty J. Flower, Sadaf Ghaem-Maghami and Robert Brown*


DOI: 10.2174/1568009617666170206105131



Review Article

Lung Cancer Stem Cells: An Epigenetic Perspective

, 18(1): 16 - 31

Samriddhi Shukla, Sajid Khan, Sonam Sinha and Syed Musthapa Meeran*


DOI: 10.2174/1568009617666170206104623



Review Article



Review Article



Review Article


Research Article

Mechanisms for the Inhibition of Colon Cancer Cells by Sulforaphane through Epigenetic Modulation of MicroRNA-21 and Human Telomerase Reverse Transcriptase (hTERT) Down-regulation

, 18(1): 97 - 106

Samantha L. Martin, Rishabh Kala and Trygve O. Tollefsbol*


DOI: 10.2174/1568009617666170206104032




Editor-in-Chief

Ruiwen Zhang
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204
(USA)
View Full Editorial Board

COPE Compliant

Journal History

Current Cancer Drug Targets was launched in 2001. Dr. Ruiwen Zhang serves as the Editor-in-Chief of the journal.
Scopus CiteScore Metrics: 2.75

Advertisement

CITATION BOOSTERNew Year Offer 2021

Related Journals

Related eBooks

eBooks Catalog